Robert Camerlinck - 31 Mar 2023 Form 4 Insider Report for Cano Health, Inc.

Role: Chief Operating Officer
Signature: /s/ David J. Armstrong, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 31 Mar 2023
Net transactions value: $0
Form type: 4
Filing time: 04 Apr 2023, 20:39:17 UTC
Previous filing: 06 Sep 2022
Next filing: 10 Apr 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CANO	Class A Common Stock	Award		+70,486	+0.3%		23,913,609	31 Mar 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CANO	Stock Option (Right to Buy)	Award	$0	+147,548		$0.000000	147,548	31 Mar 2023	Class A Common Stock	147,548	$0.9100	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares represent restricted stock units ("RSUs") granted under the Cano Health, Inc. 2021 Stock Option and Incentive Plan. Each unit represents a right to receive one share of the Issuer's Class A Common Stock. The RSUs vest as to 50% of the RSUs on December 31st, 2023 and the remaining 50% of the RSUs vest on December 31st, 2024. The RSUs were granted on March 31, 2023.
F2	The stock option is granted under the Cano Health, Inc. 2021 Stock Option and Incentive Plan and is scheduled to vest over four years, with 25% of the shares underlying the award vesting on March 31, 2024, and 25% of the shares underlying the award vesting at the end of each successive one-year period thereafter. The stock option was granted on March 31, 2023.